Predicting Relapse After Anti-TNF Cessation in Crohn's Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Gastroenterology and Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Prediction of Relapse After Anti–Tumor Necrosis Factor Cessation in Crohn's Disease: Individual Participant Data Meta-Analysis of 1317 Patients From 14 Studies
Clin. Gastroenterol. Hepatol. 2021 Apr 29;[EPub Ahead of Print], RWM Pauwels, C Janneke van der Woude, D Nieboer, EW Steyerberg, MJ Casanova, JP Gisbert, NA Kennedy, CW Lees, E Louis, T Molnár, K Szántó, E Leo, S Bots, R Downey, M Lukas, WC Lin, A Amiot, C Lu, X Roblin, K Farkas, JB Seidelin, M Duijvestein, GR D'Haens, AC de VriesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.